Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Stephane Vigouroux"'
Autor:
Avichai Shimoni, Myriam Labopin, Bipin Savani, Liisa Volin, Gerhard Ehninger, Jurgen Kuball, Donald Bunjes, Nicolaas Schaap, Stephane Vigouroux, Andrea Bacigalupo, Hendrik Veelken, Jorge Sierra, Matthias Eder, Dietger Niederwieser, Mohamad Mohty, Arnon Nagler
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-10 (2016)
Abstract Background Myeloablative (MAC) and reduced-intensity conditioning (RIC) are established approaches for allogeneic stem cell transplantation (SCT) in acute myeloid leukemia (AML). Most deaths after MAC occur within the first 2 years after SCT
Externí odkaz:
https://doaj.org/article/e4e37a309d4e423dafda6bcf95ed56c7
Autor:
Jean El Cheikh, Patrick Sfumato, Mohamad Sobh, Nathalie Fegueux, Mohamad Mohty, Stephane Vigouroux, Yves Beguin, Ibrahim Yakoub-Agha, Gerard Socié, Jerome Cornillon, Melanie Mercier, Jacques Olivier Bay, Didier Blaise, Mauricette Michallet, Regis Peffault de Latour
Publikováno v:
Haematologica, Vol 101, Iss 6 (2016)
Externí odkaz:
https://doaj.org/article/3fc5d715b76443e6933e54221a413721
Autor:
Bipin N. Savani, Myriam Labopin, Didier Blaise, Dietger Niederwieser, Fabio Ciceri, Arnold Ganser, Renate Arnold, Boris Afanasyev, Stephane Vigouroux, Noel Milpied, Michael Hallek, Jan J. Cornelissen, Rainer Schwerdtfeger, Emmanuelle Polge, Frédéric Baron, Jordi Esteve, Norbert C. Gorin, Christoph Schmid, Sebastian Giebel, Mohamad Mohty, Arnon Nagler
Publikováno v:
Haematologica, Vol 101, Iss 2 (2016)
Increasing numbers of patients are receiving reduced intensity conditioning regimen allogeneic hematopoietic stem cell transplantation. We hypothesized that the use of bone marrow graft might decrease the risk of graft-versus-host disease compared to
Externí odkaz:
https://doaj.org/article/d9770cb9b1a14200a3cc7799007f239b
Autor:
Régis Peffault de Latour, Hubert Schrezenmeier, Andrea Bacigalupo, Didier Blaise, Carmino A. de Souza, Stephane Vigouroux, Roelf Willemze, Louis Terriou, Andre Tichelli, Mohamad Mohty, Sophie de Guibert, Judith C. Marsh, Jakob Passweg, Jean Yves Mary, Gerard Socié
Publikováno v:
Haematologica, Vol 97, Iss 11 (2012)
Background In the era of eculizumab, identifying patients with paroxysmal nocturnal hemoglobinuria who may benefit from allogeneic stem cell transplantation is challenging.Design and Methods We describe the characteristics and overall survival of 211
Externí odkaz:
https://doaj.org/article/23ed429fef0c495f8cf315e48019931c
Autor:
Claire Vignaux, Dominique Plantaz, Claude-Eric Bulabois, Eva de Berranger, Bertrand Décaudin, Bruno Lioure, Yosr Hicheri, Jean-Henri Bourhis, Virginie Gandemer, Patrice Ceballos, Nathalie Contentin, Fanny Rialland, Anne Sirvent, Pascal Turlure, Leonardo Magro, Bénédicte Bruno, Stéphanie Belaiche, Nathalie Fegueux, Anne Huynh, Claire Galambrun, Valérie Coiteux, Pascal Odou, Jacques-Olivier Bay, Laure Vincent, Alexandre Caron, Stephane Vigouroux, Ibrahim Yakoub-Agha, Dominique Farge, Sophie Taque, Nicolas Depas, Natacha Maillard, Jérôme Cornillon
Publikováno v:
Fundamental & Clinical Pharmacology. 35:435-445
Medication non-adherence (NA) after allogeneic hematopoietic cell transplantation (allo-HCT) can lead to serious complications. This study assesses NA in French adult and pediatric recipients and identifies factors associated with NA. In accordance w
Autor:
Catherine Mohr, Harold IpKan Fong, Jean-francois Goussot, Noel Milpied, Marion Marty, Claire Bréal, Reza Tabrizi, Sébastien Cossin, Fanny Sauvestre, Stephane Vigouroux, Genevieve Belleannee
Publikováno v:
Virchows Archiv. 472:213-220
Gastrointestinal (GI) graft-versus-host-disease (GVHD) is a common and severe complication of allogeneic hematopoietic stem cell transplantation, but clinical and histological features are unspecific. The aim of this study was to correlate the histol
Autor:
Delcampe A, Anne Huynh, Felipe Suarez, Marie Robin, Jordan Gauthier, Stephane Vigouroux, Noel-Jean Milpied, Marie T Rubio, Leonardo Magro, Oumadely R, Stéphanie Nguyen, J.-H. Dalle, M Richet, Ibrahim Yakoub-Agha, Fagot T
Publikováno v:
Bone Marrow Transplantation
Bone Marrow Transplantation, Nature Publishing Group, 2017, 52 (6), pp.878-882. ⟨10.1038/bmt.2017.9⟩
Bone Marrow Transplantation, 2017, 52 (6), pp.878-882. ⟨10.1038/bmt.2017.9⟩
Bone Marrow Transplantation, Nature Publishing Group, 2017, 52 (6), pp.878-882. ⟨10.1038/bmt.2017.9⟩
Bone Marrow Transplantation, 2017, 52 (6), pp.878-882. ⟨10.1038/bmt.2017.9⟩
Chronic GvHD-related keratoconjunctivitis sicca (cGvHD-related KCS) can significantly alter the quality of life of patients after allogeneic hematopoietic stem cell transplantation. The aim of this work was to assess the efficacy and tolerability of
Autor:
Myriam Labopin, Philippe Moreau, Thierry Guillaume, Noel Milpied, Leonardo Magro, Pierre Peterlin, Florent Malard, Cécile Borel, Marie-Thérèse Rubio, Stephane Vigouroux, Patrice Chevallier, Reza Tabrizi, Mohamad Mohty, Ibrahim Yakoub-Agha, Alice Garnier, Béatrice Gaugler, Anne Huynh
Publikováno v:
Bone Marrow Transplantation
Bone Marrow Transplantation, Nature Publishing Group, 2019, 54 (11), pp.1815-1826. ⟨10.1038/s41409-019-0536-y⟩
Bone Marrow Transplantation, 2019, 54 (11), pp.1815-1826. ⟨10.1038/s41409-019-0536-y⟩
Bone Marrow Transplantation, Nature Publishing Group, 2019, 54 (11), pp.1815-1826. ⟨10.1038/s41409-019-0536-y⟩
Bone Marrow Transplantation, 2019, 54 (11), pp.1815-1826. ⟨10.1038/s41409-019-0536-y⟩
Thirty patients, with high-risk acute myeloid leukemia (AML, n = 20) or myelodysplastic syndrome (MDS, n = 10), were enrolled in a phase II trial entailing prophylactic post-transplant azacitidine (AZA) plus escalated doses of donor lymphocyte infusi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f0a62aeab838595ec2506d495a9669
https://hal.univ-lorraine.fr/hal-02977226
https://hal.univ-lorraine.fr/hal-02977226
Autor:
Yves Beguin, Elodie Drumez, Mauricette Michallet, Bruno Lioure, Jordan Gauthier, Martin Carre, Stephane Vigouroux, Didier Blaise, Ibrahim Yakoub-Agha, Patrice Chevallier, Felipe Suarez, Anne Huynh, Charles Dauriac, Marie Robin, Jacques-Olivier Bay, Pierre-Simon Rohrlich, Jérôme Cornillon, Jean-Henri Bourhis, Alexis Caulier, Federico Garnier, Régis Peffault de Latour, Yohan Desbrosses, Alain Duhamel, Stéphanie Nguyen
Publikováno v:
Current Research in Translational Medicine
Current Research in Translational Medicine, Elsevier-Masson SAS, 2019, 67 (1), pp.8-15
Current Research in Translational Medicine, 2019, 67 (1), pp.8-15
Current Research in Translational Medicine, Elsevier-Masson SAS, 2019, 67 (1), pp.8-15
Current Research in Translational Medicine, 2019, 67 (1), pp.8-15
Purpose We developed a prognostic scoring system to evaluate the prognosis of myelodysplastic syndrome (MDS) patients surviving more than 100 days allogeneic hematopoietic cell transplantation after (allo-HCT). Patients and methods We performed a lan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af79d36722d3f5351af8ef331aa798eb
https://hal.archives-ouvertes.fr/hal-02055904
https://hal.archives-ouvertes.fr/hal-02055904
Autor:
Arnon Nagler, Donald Bunjes, Mohamad Mohty, Jürgen Kuball, Stephane Vigouroux, Dietger Niederwieser, Avichai Shimoni, Liisa Volin, Bipin N. Savani, Hendrik Veelken, Jorge Sierra, Gerhard Ehninger, Matthias Eder, Nicolaas Schaap, Andrea Bacigalupo, Myriam Labopin
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-10 (2016)
Journal of hematology & oncology, 9. BioMed Central
Journal of Hematology and Oncology, 9
Journal of Hematology & Oncology, 9, 1, pp. 118
Journal of Hematology & Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of Hematology & Oncology, 9, 118
Journal of hematology & oncology, 9. BioMed Central
Journal of Hematology and Oncology, 9
Journal of Hematology & Oncology, 9, 1, pp. 118
Journal of Hematology & Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of Hematology & Oncology, 9, 118
Background Myeloablative (MAC) and reduced-intensity conditioning (RIC) are established approaches for allogeneic stem cell transplantation (SCT) in acute myeloid leukemia (AML). Most deaths after MAC occur within the first 2 years after SCT, while p